Human Coronary Plaque T Cells Are Clonal and Cross-React to Virus and Self | Circulation Research
Frontiers | Virus-Induced T Cell-Mediated Heterologous Immunity and Vaccine Development
T-cell-receptor cross-recognition and strategies to select safe T-cell receptors for clinical translation - ScienceDirect
Time to evolve: predicting engineered T cell-associated toxicity with next-generation models | Journal for ImmunoTherapy of Cancer
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology
Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T cells in prepandemic and COVID-19 convalescent individuals | PLOS Pathogens
Frontiers | Cross-Reactive Immunity Among Flaviviruses
Viruses | Free Full-Text | Quantifying T Cell Cross-Reactivity: Influenza and Coronaviruses
T‐cell cross‐reactivity may explain the large variation in how cancer patients respond to checkpoint inhibitors - Sioud - 2018 - Scandinavian Journal of Immunology - Wiley Online Library
Selective Expansion of Cross-Reactive Cd8+ Memory T Cells by Viral Variants | Journal of Experimental Medicine | Rockefeller University Press
Functional SARS-CoV-2 cross-reactive CD4+ T cells established in early childhood decline with age | PNAS
No one is naive: the significance of heterologous T-cell immunity | Nature Reviews Immunology
Cross‐reactivity in allergy: A double‐edged sword - Pomés - 2020 - Allergy - Wiley Online Library
Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination | Science
Broadly reactive human CD4+ T cells against Enterobacteriaceae are found in the naïve repertoire and are clonally expanded in the memory repertoire - Cassotta - 2021 - European Journal of Immunology - Wiley Online Library
TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition | SpringerLink
TIL going viral: detection of TCR cross-specificity for viral and tumor antigens
SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection - eBioMedicine
Focusing in on T Cell Cross-Reactivity - ScienceDirect
Frontiers | Heterologous Immunity: Role in Natural and Vaccine-Induced Resistance to Infections
SARS-CoV-2 infection damages CD8+ T cell response
![PDF] Frontiers in nephrology: heterologous immunity, T cell cross-reactivity, and alloreactivity. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d83ef7de5ed03a7b769927594b1bb1d00efc9c24/5-Figure3-1.png "PDF] Frontiers in nephrology: heterologous immunity, T cell cross-reactivity, and alloreactivity. | Semantic Scholar")
PDF] Frontiers in nephrology: heterologous immunity, T cell cross-reactivity, and alloreactivity. | Semantic Scholar
Cross-Reactive CD8 T-Cell Responses Elicited by Adenovirus Type 5-Based HIV-1 Vaccines Contributed to Early Viral Evolution in Vaccine Recipients Who Became Infected | Journal of Virology
Association of cellular immunity with severity of COVID-19 from the perspective of antigen-specific memory T cell responses and cross-reactivity | Inflammation and Regeneration | Full Text
